Global PTCA Balloon Catheter Market 2015-2019
About PTCA Balloon Catheter
PTCA is a minimally invasive procedure to open up blocked coronary arteries to permit unhindered blood flow to the heart muscle. In this procedure, catheters are positioned within the arteries to compress the plaques within a clogged coronary artery. A PTCA balloon catheter is a type of soft catheter equipped with a tiny inflatable balloon at its tip, which is inserted during a catheterization procedure into an artery that has been constricted by the addition of fatty deposits. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheters were the first devices used in the field of interventional cardiology. These catheters are also employed in the positioning of stents during angioplasty. PTCA balloon catheters are used in the PTCA procedures to compress the plaques within a blocked coronary artery.
Technavio's analysts forecast the global PTCA balloon catheter market to grow at a CAGR of 3.48% during 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the global PTCA balloon catheter market for 2015-2019. The market can be segmented into four divisions: normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. To calculate the market size, we consider the revenue generated from these PTCA balloon catheters.
Technavio's report, Global PTCA Balloon Catheter Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key Regions
Technavio Announces the Publication of its Research Report – Global PTCA Balloon Catheter Market 2015-2019
Technavio recognizes the following companies as the key players in the Global PTCA Balloon Catheter Market: Abbott Laboratories, Boston Scientific, Medtronic and Terumo
Other Prominent Vendors in the market are: Aachen Resonance, Acrostak, Alvimedica, AngioScore, Arthesys, Asahi Intecc, Atrium Medical, B. Braun Melsungen, Biosensors International, BIOTRONIK, C.R. Bard, Cook Medical, Cordis, MicroPort Scientific, Natec Medical, Smiths Medical, Terumo Medical, Tokai Medical Products and Volcano
Commenting on the report, an analyst from Technavio’s team said: “The elderly population worldwide is increasingly opting for minimally invasive surgeries. Advances in PTCA balloon catheters have led to an increased number of clinical trials and the launch of new products in the market. These procedures are performed through small incisions in the body and can be used to treat plaque obstructions in the arteries of the heart and other blood vessels of peripheral organs, such as the brain and kidneys. These procedures are advantageous over conventional surgical methods as they offer a short recovery time, low risk of infection, cost-effectiveness, reduced scars resulting in less physical trauma, minimized bleeding, and shorter hospital stays.”
According to the report, the high demand for minimally invasive procedures in interventional cardiology to treat CHDs and PVDs will likely contribute to market growth. These procedures are advantageous over conventional surgeries, have low risk, and leave fewer scars after the operation.Further, the report states that the increased use of self-expanding stents, which do not require balloon catheters, also limits market growth.
Abbott Laboratories, Boston Scientific, Medtronic, Terumo, Aachen Resonance, Acrostak, Alvimedica, AngioScore, Arthesys, Asahi Intecc, Atrium Medical, B. Braun Melsungen, Biosensors International, BIOTRONIK, C.R. Bard, Cook Medical, Cordis, MicroPort Scientific, Natec Medical, Smiths Medical, Terumo Medical, Tokai Medical Products, Volcano
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook